Overcoming Geography With Technology: Medical Drones Project
NCT05259761 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1450
Last updated 2022-03-02
Summary
In this study, the investigators shall evaluate the use unmanned air vehicles (medical drones) to deliver ART to adult patients eligible/enrolled in community DSD models in Bufumira Islands, Kalangala district. The geography of the islands is ideal for this project because of the flat landscape and water coverage. The investigators hypothesize that the use of drones would be acceptable to patients and stakeholders, reduce facility drug stock outs, increase retention in care by 10% in intervention (at 12 months) compared to the control health centres and be cost neutral (to the patients and health sector perspectives). The investigators will also undertake evaluation of an efficient sample delivery system using medical drones especially for expansive rural areas like Moyo and Adjumani.
Conditions
- Sexually Transmitted Infections (Not HIV or Hepatitis)
- HIV Infections
- COVID-19
Interventions
- OTHER
-
Unmanned ariel vehicle
Use of an Unmanned ariel vehicle for medical delivery (drugs and samples)
Sponsors & Collaborators
- collaborator INDUSTRY
-
Rakai Health Sciences Program
collaborator OTHER -
Makerere University
lead OTHER
Principal Investigators
-
Rosalind Parkes-Ratanshi, PhD · Infectious Diseases Institute
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-09-22
- Primary Completion
- 2022-03-22
- Completion
- 2022-06-30
Countries
- Uganda
Study Locations
More Related Trials
-
Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients
NCT04212377 ·Status: COMPLETED ·Phase: PHASE2
-
Vaccination of Patients With Stage IV Melanoma With Dendritic Cells
NCT00125749 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
DC Vaccination in CML
NCT02543749 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Dendritic Cell-based Immunotherapy in Mesothelioma
NCT00280982 ·Status: COMPLETED ·Phase: PHASE1
-
Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
NCT01171469 ·Status: COMPLETED ·Phase: PHASE1
-
A Therapeutic Protocol in Previous Failed ART Patients With High Total NK Cells
NCT03792997 ·Status: COMPLETED ·Phase: PHASE2
-
Immunotherapy: Care and Prevention of Infectious and Tumoral Diseases (ImmunoHUB)
NCT06914635 ·Status: RECRUITING
-
Autologous Decidual-like Natural Killer Cells Therapy for Reproductive Failure
NCT07230574 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Advanced Malignant Melanoma
NCT01278940 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients
NCT00929019 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor
NCT00377247 ·Status: TERMINATED ·Phase: PHASE1
-
The Impact of CAR-T Cell Therapy on Fertility; A Patient Survey
NCT07173322 ·Status: RECRUITING
-
Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells
NCT00672542 ·Status: COMPLETED ·Phase: PHASE1
-
Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA
NCT00006431 ·Status: UNKNOWN ·Phase: PHASE1
-
Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection
NCT00243594 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma
NCT00625755 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tumor RNA Transfected Dendritic Cell Vaccines
NCT00108264 ·Status: COMPLETED ·Phase: PHASE1
-
Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients
NCT00243529 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Dendritic Cell Therapy for Myeloid Leukemia and Myeloma
NCT00965224 ·Status: COMPLETED ·Phase: PHASE2
-
Natural Killer Cells Reconstitution Kinetics Post Haploidentical Transplantation
NCT02978274 ·Status: UNKNOWN
-
Dendritic Cell Based Therapy of Malignant Melanoma
NCT00197912 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer
NCT03114631 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
CART-meso Long-term Follow-up
NCT02388828 ·Status: COMPLETED
-
DC Vaccination for Postremission Therapy in AML
NCT01734304 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade Gliomas
NCT06253234 ·Status: RECRUITING ·Phase: PHASE1